Establishing pharmaceutical drugability profiles from minute amounts of bulk.
Timely performing the right studies and discarding the useless ones.
Preventing the risk of running twice expensive studies like in vivo ones.
Early indicating the most appropriate drug delivery options for going to clinic.

Careful listening to understand the actual need, timelines and study goals.
Repositioning the study objectives in the overall context of the project.
Highlighting the issues that were not always understood by the client.
Customising the study design to faster bring the right answer.

Securing faster Proof-of-Concept study outcomes.
Faster selecting compounds aligned with the desired Target Product Profiles.
Early making recommendations on crystallisation conditions and media.
Identifying appropriate drug delivery options for preclinical & clinical development.

Efficient enabling formulations for faster establishing Proofs-of-Concept.
Pharmaceutical drugability as part of the drug candidate selection criteria.
Recommendations on crystal form choice before API scale-up studies.
Best drug delivery options identified before clinical dosage form development start.

Knowledge sharing all along the project to secure the decision-making process.
Fully interpreted results presented in highly comprehensive research reports.
Clear recommendations for the next steps based on decades of experience.
Existing connections to a large network of complementary CROs and CDMOs.